How to Use BPC-157: Administration, Reconstitution & Storage (2026)

From Peptidepedia, the trusted peptide wiki.

How to Use / Administration Methods

Subcutaneous Injection (Most Common)

Subcutaneous injection into the fatty tissue of the abdomen, thigh, or near the injury site is the most widely used method. The slower absorption profile of subcutaneous delivery suits BPC-157's mechanism: as a tissue-signaling peptide, it benefits from sustained presence in circulation rather than rapid spikes. Injecting close to the affected area is believed by some to provide more localized effects, though systemic distribution occurs regardless of injection site.

Intramuscular Injection

Some users prefer intramuscular injection, particularly when targeting specific muscle injuries. This method may provide more direct delivery to affected muscle tissue.

Oral Administration

Most peptides cannot survive oral delivery — the sequential barriers of stomach acid, intestinal enzymes, and first-pass liver metabolism degrade peptide bonds before they reach systemic circulation. BPC-157 is a rare exception. Originating from a protective protein in human gastric juice, it possesses intrinsic acid stability without requiring special formulation or absorption enhancers. This makes oral administration viable, particularly for gastrointestinal applications where the peptide can act locally on the gut lining. Oral capsules and sublingual formulations are available, though systemic bioavailability may differ from injectable forms — whether oral BPC-157 can reach distant injury sites at therapeutic concentrations remains an open question. For gut-focused protocols, see our [best peptides for gut health guide](/guides/best-peptides-for-gut-health).

Intra-articular Injection

For joint-related issues, some practitioners have utilized intra-articular injection. One retrospective study found that 7 of 12 patients with chronic knee pain reported symptom improvement lasting more than 6 months following a single intra-articular BPC-157 injection.

Reconstitution, Storage & Prep

BPC-157 typically comes as a lyophilized (freeze-dried) powder that requires reconstitution before use.

Reconstitution Process:

Allow the BPC-157 vial to reach room temperature
Use bacteriostatic water (BAC water) as the reconstitution fluid (this contains 0.9% benzyl alcohol as a preservative)
Draw the appropriate amount of BAC water into an insulin syringe
Inject the water slowly down the inside wall of the vial, allowing it to gently dissolve the powder
Do not shake vigorously, but gentle swirling is acceptable
Allow the solution to sit until fully dissolved (typically a few minutes)

Common Reconstitution Ratio:

5 mg BPC-157 + 5 mL BAC water = 1 mg/mL (100 mcg per 0.1 mL / 10 units on an insulin syringe)

Storage Guidelines:

Lyophilized (unreconstituted) BPC-157: Store below -18°C (-0.4°F) for long-term storage; stable at room temperature for approximately 3 weeks
Reconstituted BPC-157: Store at 2 to 8°C (refrigerator temperature) and use within 4 weeks
Protect from light and avoid repeated freeze-thaw cycles
Never use the solution if it appears cloudy or contains particles

Frequently Asked Questions

Preclinical animal studies have shown no acute toxicity across multiple organ systems at various doses over 6-week periods. However, human clinical safety data are essentially nonexistent. The FDA has expressed concerns about potential immunogenicity and unknown long-term effects. Additionally, unregulated manufacturing creates contamination risks.

Individual responses vary significantly. Some users report initial improvements in inflammation and pain within 1 to 2 weeks, with more substantial healing benefits observed over 4 to 8 weeks. The peptide has a short half-life of less than 30 minutes, requiring daily, consistent dosing. We do not yet understand the best method of dosing.

Yes, BPC-157 demonstrates unusual stability in gastric acid, making oral administration viable. Oral forms may be particularly suitable for gastrointestinal applications. However, it is not clear if BPC-157 can be transported from the stomach to a distant site of action somewhere else in the body. Therefore, oral administration may only have limited applications.

Subcutaneous injection is a common method, with the option to inject near injury sites. Intramuscular injection is preferred by some for muscle injuries. Oral administration is viable, particularly for gut-related applications, though absorption characteristics may differ.

Lyophilized (powder) BPC-157 should be stored below -18°C for long-term storage, though it remains stable at room temperature for approximately 3 weeks. Once reconstituted with bacteriostatic water, store at 2 to 8°C (refrigerator) and use within 4 weeks. Protect from light and avoid freeze-thaw cycles.

This content is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.